Wall Street Journal : FTC Accuses Drug Middlemen of Inflating Insulin Prices

 

#Business #WallStreet

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.

Read More  

WSJ.com: US Business  

PAID 

This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.

Leave a Reply

Generated by Feedzy